| Key Term/Abbreviation | Definition |
| (I, II, III, IV, V) | Complexes I-V of the mitochondrial respiratory chain |
| 1,25-dihydroxyvitamin D | 1,25(OH)2D |
| 2′-PP | 2′-Phosphophloretin |
| 2,3-BPG | 2,3-Bisphosphoglycerate |
| AD | Autosomal dominant |
| AKT | Protein kinase B |
| Alp | Alkaline phosphatase |
| AMP | Adenosine monophosphate |
| AMPK | AMP-activated protein kinase |
| AR | Autosomal recessive |
| ATP | Adenosine triphosphate |
| BBMV | Brush border membrane vesicle |
| BPG | Bisphosphoglycerate |
| CASR | Calcium-sensing receptor |
| CKD | Chronic kidney disease |
| c-myb | V-myb avian myeloblastosis viral oncogene homolog |
| CrP | Creatine phosphate |
| CYP24A1 | The vitamin D 24-hydroxylase |
| CYP27B1 | The vitamin D 1-α hydroxylase |
| DMP1 | Dentin matrix acidic phosphoprotein 1 |
| DNA | Deoxyribonucleic acid |
| EGF | Epidermal growth factor |
| EGR1 | Early growth response 1 |
| Enpp1 | Ectonucleotide pyrophosphatase-phosphodiesterase family member 1 |
| ER | Endoplasmic reticulum |
| ERK1 | Extracellular signal-regulated kinase 1 |
| ERK2 | Extracellular signal-regulated kinase 2 |
| Etv5 | ETS variant 5 |
| FADH | Flavin adenine dinucleotide |
| FAM20c | Golgi-associated secretory pathway kinase |
| FAP | Fluorapatite mineral |
| FGF | Fibroblast growth factor |
| FGF23 | Fibroblast growth factor 23 |
| FGFR1 | Fibroblast growth factor receptor 1 |
| FGFR1c | FGFR1 isoform c |
| FRS2 | FGFR substrate 2 |
| GALNT3 | Polypeptide N-Acetylgalactosaminyltransferase 3 |
| GC | Glucocorticoid |
| GCMB | Glial cell missing gene |
| GI | Gastrointestinal |
| GNAS | Guanine nucleotide-binding protein, alpha stimulating |
| GRB2 | Growth factor receptor bound protein 2 |
| HVDDR | Hereditary 1,25(OH)2D-resistant rickets |
| IBGC | Idiopathic basal ganglia calcification |
| IC | Intracellular |
| ICF | Intracellular fluid |
| IU | International units |
| IP6K1 | Inositol hexakisphosphate kinase 1 |
| IP6K2 | Inositol hexakisphosphate kinase 2 |
| IP6 | Inositol hexakisphosphate |
| IP7 | 5-diphosphoinositol 1,2,3,4,6-pentakisphosphate |
| IP8 | 1,5-bisdiphosphoinositol 1,2,3,4-tetrakisphosphate |
| IV | Intravenous |
| JAM2 | Junctional adhesion molecule 2 |
| KL | α-Klotho |
| Km | Michaelis-Menten affinity constant |
| LOF | Loss of function |
| LVH | Left ventricular hypertrophy |
| MAPK | Mitogen-activated protein kinase |
| MAPK1 | Mitogen-activated protein kinase 1 |
| MAPK3 | Mitogen-activated protein kinase 3 |
| MEPE | Matrix extracellular phosphoglycoprotein |
| mPTP | Mitochondrial permeability transition pore |
| MV | Matrix vesicle |
| MYORG | Myogenesis regulating glycosidase |
| Na+ | Sodium ion |
| NAD | Nicotinamide adenine dinucleotide |
| NADH | Reduced nicotinamide adenine dinucleotide |
| NADPH | Reduced nicotinamide adenine dinucleotide phosphate |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NHE3 | Sodium/hydrogen exchanger isoform 3 |
| NHERF-1 | Na+/H+ exchanger regulatory factor |
| NOS | Nitric oxide synthase |
| NPT1 | Sodium-dependent phosphate transport protein 1 |
| NPT2a | Sodium-dependent phosphate transport protein 2a |
| NPT2b | Sodium-dependent phosphate transport protein 2b |
| NPT2c | Sodium-dependent phosphate transport protein 2c |
| NVU | Neurovascular unit |
| OPG | Osteoprotegerin |
| OPN | Osteopontin |
| P10 | Postnatal day 10 |
| PDGFB | Platelet-derived growth factor subunit B |
| PDGFRB | Platelet-derived growth factor receptor beta |
| PFA | Phosphonoformate/phosphonoformic acid |
| PFBC | Primary familial brain calcification |
| Phex | Phosphate-regulating endopeptidase homolog, X-linked |
| PHOSPHO1 | Phosphoethanolamine/phosphocholine phosphatase 1 |
| Pi | Inorganic phosphate |
| PIC | Mitochondrial phosphate carrier |
| PIT1 | Type III sodium-dependent phosphate transporter 1 |
| PIT2 | Type III sodium-dependent phosphate transporter 2 |
| PKA | Protein kinase A |
| PKC | Protein kinase C |
| PLCγ | Phospholipase C gamma isoform. |
| PPi | Pyrophosphate |
| PPIs | Proton pump inhibitors |
| PTH | Parathyroid hormone |
| PTHR1 | Parathyroid hormone 1 receptor |
| RANK | Receptor activator of NF-κB |
| RANKL | Receptor activator of NF-κB ligand |
| RDA | Recommended daily allowance |
| RNA | Ribonucleic acid |
| ROS | Reactive oxygen species |
| RXR | Retinoic acid X-receptor |
| SAMD9 | Sterile alpha motif domain containing 9 |
| SIBLING | Small integrin-binding ligand, N-linked glycoprotein |
| SLC17 | Solute carrier family 17 |
| SLC20A1 | Solute carrier family 20 member 1; gene encoding PIT1 |
| SLC20A2 | Solute carrier family 20 member 2; gene encoding PIT2 |
| SLC25A3 | Solute carrier family 25 member 3; gene encoding PIC |
| SLC34A1 | Solute carrier family 34 member 3; gene encoding NPT2a |
| SLC34A2 | Solute carrier family 34 member 2; gene encoding NPT2b |
| SLC34A3 | Solute carrier family 34 member 3; gene encoding NPT2c |
| SM | Standard medium |
| SOS | Son of sevenless |
| SPX | A protein domain named after SYG1/Pho81/XPR1 proteins |
| TEER | Transepithelial electrical resistance |
| TNAP | Tissue non-specific alkaline phosphatase |
| TNFRSF11B | TNF receptor superfamily member 11B |
| VATP | ATP flux |
| VDR | Vitamin D receptor |
| VRE | Vitamin D-reponsive elements |
| VSMC | Vascular smooth muscle cell |
| WNT | Wingless-related integration site |
| WT | Wild-type |
| XLH | X-linked hyperphosphatemia |
| XPR1 | Xenotropic and polytropic retrovirus receptor 1 |